|
|
Volumn 370, Issue 5, 2014, Pages 478-480
|
|
Albumin-bound paclitaxel plus gemcitabine in pancreatic cancer [1]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GEMCITABINE;
PACLITAXEL;
FLUOROURACIL;
FOLINIC ACID;
IRINOTECAN;
OSTEONECTIN;
OXALIPLATIN;
ALBUMINOID;
ANTINEOPLASTIC AGENT;
DEOXYCYTIDINE;
DRUG DERIVATIVE;
CANCER SURVIVAL;
DISEASE DURATION;
DISEASE SEVERITY;
DRUG COST;
FATIGUE;
HUMAN;
LETTER;
MEDICARE;
NEUROPATHY;
PANCREAS CANCER;
PRIORITY JOURNAL;
REIMBURSEMENT;
RISK BENEFIT ANALYSIS;
CANCER LOCALIZATION;
CANCER PROGNOSIS;
CHOLANGITIS;
DISEASE ASSOCIATION;
METASTASIS;
NEUTROPENIA;
PANCREAS ADENOCARCINOMA;
ADENOCARCINOMA;
FEMALE;
MALE;
NOTE;
PANCREAS TUMOR;
ADENOCARCINOMA;
ALBUMINS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
DEOXYCYTIDINE;
FEMALE;
HUMANS;
MALE;
PACLITAXEL;
PANCREATIC NEOPLASMS;
|
|
EID: 84893036056
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc1314761 Document Type: Letter |
|
Times cited : (24)
|
|
References (3)
|
